Leading in soy technology

Nutri Pharma ASA is one of the leaders in soy technology for treatment and prevention of lifestyle-related diseases and has developed unique patent protected products, in the following fast growing areas:

Weight management & meal replacement products
Dietary supplements for heart health, female health and sports nutrition
Functional foods for cholesterol reduction
These products have been documented through more than 40 clinical and preclinical studies, carried out to pharmaceutical standards. Nutri Pharma has invested considerable capital in the scientific validation of its product development and patents.

Nutri Pharma
Nutri Pharma ASA is a public limited company under Norwegian law. Incorporated in January 1993, it was listed on the Oslo Stock Exchange in May 2000 and acquired Meridian International Group Ltd in September 2005. Nutri Pharma has three employees at its Oslo headquarters and a lean marketing and sales organization based on outsourcing. The Nutri Pharma share is registered in the Norwegian Central Securities Depository (VPS) and listed on the Oslo Stock Exchange, under the ticker code NUT.

Since its establishment in 1993, Nutri Pharma has become one of the leaders in soy technology for treatment and prevention of life-style related diseases. It has developed a number of unique patented products that are documented by extensive clinical trials, well proven in the Nordic market, and protected by patents.

In 2005, Nutri Pharma began realigning its operations in accordance with a new business model. This involves changing its main distribution focus from international cooperative relationships to direct sales. The company is now committed to achieving a position as a supplier of its patented health and weight reduction products, and selected third-party health care and nutrition products, through direct sales in key markets abroad.

In 2008, Nutri Pharma entered into a Distribution, Product Supply and Marketing support agreement with Nikken UK Ltd. for the European launch of it Nutri5® female health product through Nikken's direct marketing network. Nutri5® was subsequently launched into 17 European markets in May 2009.

In August 2009, the agreement with Nikken was extended to encompass distribution within Russia and the CIS. At the same time, the Meridian International Group was sold to an American Multi-Level Marketing company.